FDA.reportPublic FDA data

Ultimate Seer Sunscreen SPF 55

Manufacturer
Rite Aid | Product Quest Mfg
Effective date
2018-07-20
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:56:21

Label at a glance#

ProductUltimate Seer Sunscreen SPF 55 daylogic
Active ingredientAvobenzone, Homosalate, Octisalate, Octocrylene, Oxybenzone
Label structure7 sections

Indications and uses

• helps prevent sunburn • higher SPF gives more sunburn protection

Dosage and administration

• apply liberally 15 minutes before sun exposure • reapply:   - after 80 minutes of swimming or sweating   - immediately after towel drying   - at least every 2 hours • Sun Protection Measures . Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen SPF of 15 or higher and other sun protection measures including:   - limit time in the sun,...

Label contents#

Full prescribing information#

Active ingredients                   Purpose

OTC - ACTIVE INGREDIENT SECTION

Avobenzone - 3.00%                Sunscreen
Homosalate - 10.00%               Sunscreen
Octisalate - 5.00%                    Sunscreen
Octocrylene - 2.75%                 Sunscreen
Oxybenzone - 6.00%                Sunscreen

Uses

INDICATIONS & USAGE SECTION

• helps prevent sunburn
• higher SPF gives more sunburn protection

WarningsFor external use only

WARNINGS SECTION

Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash occurs

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of the children. If product is swallowed, get medical help or contact a Poison Control Center right away

Directions

DOSAGE & ADMINISTRATION SECTION

• apply liberally 15 minutes before sun exposure
• reapply:
  - after 80 minutes of swimming or sweating
  - immediately after towel drying
  - at least every 2 hours
• Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen SPF of 15 or higher and other sun protection measures including:
  - limit time in the sun, especially from 10 a.m. – 2 p.m.
  - wear long sleeve shirts, pants, hats, and sunglasses
• children under 6 month: Ask a doctor

Inactive ingredients

INACTIVE INGREDIENT SECTION

Behenyl Alcohol, BHT, Butyloctyl Salicylate, Caprylyl Methicone, Dimethicone, Dimethyl Capramide, Disodium EDTA, Ethylhexyl Stearate,
Ethylhexylglycerin, Ethylparaben, Fragrance, Glyceryl Stearate, Iodopropynyl Butylcarbamate, Methylparaben, PEG-100 Stearate, Phenoxyethanol, Polyester-8, Propylparaben, Silica, Sodium Polyacrylate, Styrene/Acrylates Copolymer, Trideceth-6, Trimethylsiloxysilicate, VP/Hexadecene Copolymer, Water, Xanthan Gum

Other information

OTHER SAFETY INFORMATION

• protect this product from excessive heat and direct sun • may stain fabrics

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image descriptionimage description

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130011822113342GTIN-13: 0011822113342
EAN-13: 0011822113342
GTIN-12: 011822113342
UPC-A: 011822113342
GTIN storage (14 digits): 00011822113342		label.jpg

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
11822-1241-32020-01-31C16284748780-19d75b9d0-0b08-f424-e053-dadaa90a57ceDrug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
11822-1241-3Ultimate Seer Sunscreen SPF 55daylogic89 mL in 1 TUBELOTION892

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
11822-1241ULTIMATE SEER SUNSCREEN SPF 55 DAYLOGIC (AVOBENZONE - 3.00% HOMOSALATE - 10.00% OCTISALATE - 5.00% OCTOCRYLENE - 2.75% OXYBENZONE - 6.00%) LOTION [RITE AID]2Legacy NDC, 1 package rows20180720_2e3e6aec-20d8-49b2-a39c-b9f46f0ceab9.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 29 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
11822-124111822-1241-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 27 matching rows.

Name, UNII, Kind table
NameUNIIKind
AvobenzoneG63QQF2NOXACTIB
HomosalateV06SV4M95SACTIB
Octisalate4X49Y0596WACTIB
Octocrylene5A68WGF6WMACTIB
Oxybenzone95OOS7VE0YACTIB
DOCOSANOL9G1OE216XYIACT
BUTYLATED HYDROXYTOLUENE1P9D0Z171KIACT
Butyloctyl Salicylate2EH13UN8D3IACT
CAPRYLYL TRISILOXANEQ95M2P1KJLIACT
Dimethicone92RU3N3Y1OIACT
Dimethyl CapramideO29Y6X2JEZIACT
EDETATE DISODIUM ANHYDROUS8NLQ36F6MMIACT
Ethylhexyl StearateEG3PA2K3K5IACT
Ethylhexylglycerin147D247K3PIACT
Ethylparaben14255EXE39IACT
GLYCERYL MONOSTEARATE230OU9XXE4IACT
Iodopropynyl Butylcarbamate603P14DHEBIACT
MethylparabenA2I8C7HI9TIACT
PEG-100 StearateYD01N1999RIACT
PhenoxyethanolHIE492ZZ3TIACT
POLYESTER-8 (1400 MW, CYANODIPHENYLPROPENOYL CAPPED)T9296U138PIACT
PropylparabenZ8IX2SC1OHIACT
SILICON DIOXIDEETJ7Z6XBU4IACT
Trideceth-63T5PCR2H0CIACT
VINYLPYRROLIDONE/HEXADECENE COPOLYMERKFR5QEN0N9IACT
WATER059QF0KO0RIACT
Xanthan GumTTV12P4NEEIACT

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
7282631a-3d93-4b1f-9e0d-674431a59ff72e3e6aec-20d8-49b2-a39c-b9f46f0ceab92018-07-20WarningsExact identifier
spl id: 7282631a-3d93-4b1f-9e0d-674431a59ff7
spl set id: 2e3e6aec-20d8-49b2-a39c-b9f46f0ceab9

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.